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 The retinal retinal ganglion cell layer (GCL) is comprised
of several distinct cell types located in intimate contact with
one another. Most prominent among these are retinal ganglion
cells (RGC), astrocytes, and amacrine cells, but microglia are
also occasionally observed. In addition, distinct subpopula-
tions of each cell type have been described based on morpho-
logical appearance or discrete histochemical markers [1]. To
date, information regarding the molecular composition and
characteristics of ganglion cell subtypes remains incomplete,
particularly with respect to the distinguishing characteristics
of individual subtypes of ganglion cells.
The paucity of molecular information about the resident
cells of the GCL is partly due to the morphological organiza-
tion of the tissue where RGC, glial cells, and amacrine cells
are found in very close proximity. Amacrine cells in particu-
lar represent a sizeable fraction of cells present in this layer,
contributing over 50% of cells in the human midperipheral
GCL [2]. The identification of gene products that, within the
retina, are specific to the GCL, or are highly enriched in the
GCL as compared to other retinal layers, would provide use-
ful information for selecting novel molecular markers, identi-
fying functional characteristics of cellular populations, and
ultimately aiding in the development of treatment regimens
directed at distinct cell types through specific receptors or gene
therapy vectors driven by highly selective promoters.
Arguably the most important function of the GCL is the
transmission of stimuli from the sensory retina via RGC to
the visual centers of the brain. In addition, RGC appear to be
involved in other important processes, e.g. melanopsin con-
taining RGC contribute to the regulation of circadian rhythms
[3]. A number of ocular neuropathies are accompanied by
pathophysiological events in the GCL. Loss of vision in the
glaucomas, the most common group of these afflictions, oc-
curs despite adequate photoreceptor function and is caused by
the slow, progressive death of RGC [4,5]. While the demise
of RGC is ultimately the cause for vision loss, other cell types
present in the GCL, in particular microglia or astrocytes, may
contribute to this neuronal degeneration through the release
of molecules harmful to neurons [6].
Recently several investigators have presented gene ex-
pression profiles of rat RGC purified by immunopanning fol-
lowing enzymatic dissociation of the retina [7,8]. This method
allows for the isolation of highly enriched RGC fractions.
However, it removes the cells from their natural environment
and is likely to alter some aspects of the RGC expression pro-
file. One alternative approach is to isolate the cells of the GCL
using laser capture microdissection (LCM) and to employ
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bioinformatics approaches to identify GCL specific gene ex-
pression through the computational subtraction of those genes
also expressed elsewhere in the retina. While this method is
effective to remove genes shared with most cell types, one
limitation of this approach is that gene products derived from
the astrocytes of the nerve fiber layer can not be reliably ex-
cluded. Thus the removal of shared gene transcripts will re-
sult in a catalog of genes likely to be either RGC or astrocyte
derived. In this report we used LCM to isolate cells from the
GCL of three adult normal human eye donors as well as from
the inner and outer nuclear and inner and outer plexiform lay-
ers from the same donors. The resulting catalog of GCL spe-
cific molecules represents a resource for the identification of
candidate genes for hereditary forms of glaucoma,
bioinformatics analyses of retinal gene expression patterns,
and the identification of target molecules for pharmacological
approaches aimed at neuroprotection of RGC.
METHODS
Human donor tissue:  Human eyes of adult donors without
retinal or optic nerve disease (ages 72, 75, and 91) were ob-
tained from the Iowa Lions Eye Bank and preserved within 5
h postmortem (see below). The clinical history of all donors
was reviewed by a board certified ophthalmologist (YHK) prior
to use of the tissue. Donors included in this study did not have
a history of diabetes, age-related macular degeneration, glau-
coma, other neurodegenerative diseases, and were without
abnormal finding upon dissection (Figure 1).
Laser capture microdissection and RNA isolation:  For
LCM portions of the neural retina from the central to mid-
periphery area were isolated from one eye of the three human
donors described above. Tissue was obtained from the area
between three disk diameters peripheral to the foveola and the
vortex vein inlet (approximately 4.5-10 mm from the foveola).
Tissue was embedded in optimal cutting temperature (OCT)
medium (Tissue-Tek®, Sakura Finetek, Torrance, CA) with-
out prior fixation and stored at -80 °C until the completion of
medical records review.
Tissue was sectioned to a thickness of 7 µm using a cryo-
microtome (HM 505E microtome, Microme Laborgeräte,
Walldorf, Germany) and dehydrated through a graded series
of ethanol followed by incubation in xylenes. Laser capture
microdissection was performed using the PixCell® II system
(Arcturus Bioscience, Inc., Mountain View, CA) and
CapSure® LCM macro caps (Arcturus). Laser settings were
from 60 to 100 mW in power, 5.0-10.0 ms in duration, and a
laser spot size of 7.5 µm was used. Fractions were captured
separately along the entire length of the section and an esti-
mated 1,000 cells were obtained from each sample. Follow-
ing collection, tissue was removed from the LCM cap and
RNA was isolated using the PicoPure® RNA extraction kit
(Arcturus) following the manufacturer’s protocol, including
DNAse treatment, and stored at -80 °C until further process-
ing.
Prior to T7-RNA polymerase based amplification the qual-
ity and quantity of the isolated RNA was assessed by real-
time PCR. Briefly, 5% of the obtained material was reverse
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Figure 1. Gross morphological appearance of the human donor eyes
used for laser capture microdissection.  Only eyes free of ocular pa-
thology based upon donor’s chart review and post-mortem retinal
examination were used in this study.
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transcribed in an oligo(dT)18 primed reaction. Real time PCR
was then carried out using the QuantiTect SYBR Green PCR
Kit (Qiagen) and an ABI Prism® 7700 Sequence Detection
System (Applied Biosystems, Foster City, CA). Amplifica-
tion values obtained for glyceraldehyde 3-phosphate dehydro-
genase (for primer sequences see Table 1) were compared to a
standard curve and the approximate yield was calculated.
RNA linear amplification and probe synthesis:  Linear
amplification and cRNA synthesis were carried out in a two-
round amplification protocol using the RiboAmp® HS RNA
Amplification Kit (Arcturus). Briefly, 500 pg-1 ng total RNA
was reverse transcribed using an oligo(dT) primer bearing a
T7 promoter sequence. Following synthesis of double-stranded
cDNA, cRNA was created through T7 RNA polymerase based
in vitro transcription (IVT). The obtained cRNA was then again
converted into cDNA and a second IVT reaction was carried
out in the presence of biotinylated UTP and CTP (PerkinElmer,
Boston, MA). The resulting biotinylated cRNA was purified
and analyzed by agarose gel electrophoresis. Samples display-
ing adequate size distribution (i.e. majority of product >300
bp) were used directly for gene array analyses.
Array hybridization and data analysis:  cRNA probes from
each donor’s GCL and OR were individually hybridized to
Affymetrix Hu133Plus 2.0 GeneChips® (Affymetrix, Inc.,
Santa Clara, CA) according to the recommendations of the
manufacturer (six hybridizations total). The fluorescence sig-
nals were detected with an HP GeneArray scanner (Hewlett-
Packard, Palo Alto, CA). Data derived were evaluated to en-
sure that the number of detected genes, the scale factor, and
the 5' to 3' probe set values of the housekeeping controls were
comparable between all hybridizations. Raw data from all
samples were normalized using the GC-RMA algorithm. To
ascertain that pure fractions of GCL cells or inner and outer
nuclear layer cells were obtained, the detected expression lev-
els of the NR2E3, IMPG1 and NEF3 genes were examined in
all samples. These genes are only expressed either in the outer
nuclear layer (IMPG1 and NR2E3) or in ganglion cells (NEF3)
[9-11]. Only those data sets that displayed at least 50 fold en-
richment of these genes in the appropriate fraction were judged
to be sufficiently pure to be included in subsequent analysis.
The probe sets used were: 207054_at (IMPG1), 208388_at
(NR2E3), and 205113_at (NEF3).
Prior to statistical analysis, probe sets that did not display
differential expression (i.e. >2 fold expression change between
the highest and lowest value) were excluded from further analy-
ses. Likewise, probe sets that did not appear to be expressed
in the retina (i.e. normalized expression values >100 in at least
one sample) were removed. Expression values were trans-
formed to log2 based values and statistical significance was
calculated by two-tailed paired t-test analysis based upon the
data obtained from the GCL and inner and outer nuclear layer
fractions of each individual donor. p-values <0.05 were con-
sidered significant.
Data were independently analyzed using the Significance
Analysis of Microarrays (SAM) algorithm, version 2.21 [12].
A delta value of 0.6 was selected in a two class paired re-
sponse type analysis. The false discovery rate was estimated
through 200 permutation tests, using the K-nearest neighbors
as the imputation engine. Under these parameters the false
discovery rate was 0% and no false positive signals were pre-
dicted when a 10 fold expression change cut-off value was
applied.
Real-time PCR:  Expression changes were confirmed for
selected genes by real-time PCR analysis using the primers
listed in Table 1. Independent batches of mRNA were obtained
from all donors by LCM as described above. The forward and
reverse primers of each primer pair correspond to regions sepa-
rated by at least one intron to prevent amplification due to
trace amounts of genomic DNA. Samples were analyzed in
triplicate and PCR reactions were carried out as described
above. Expression values were normalized to those of the
GAPDH gene as described previously [13].
Immunohistochemistry:  Tissue from three additional eye
donors was used for immunohistochemistry. Retinal tissue was
fixed in 4% paraformaldehyde, infiltrated with increasing con-
centrations of sucrose and frozen in OCT medium [14]. As
above, 7 µm section were cut with a cryo-microtome and in-
cubated with the antibody EH7A (developed by Dr. J.D. Ernst
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TABLE 1. OLIGONUCLEOTIDE PRIMERS USED DURING REAL-TIME POLYMERASE CHAIN REACTION
PRPH represents peripherin; STMA2 represents stathmin-like 2; SRPX represents sushi repeat-containing protein; ELAVL2 represents em-
bryonic lethal, abnormal vision like 2; RBPMS represents RNA-binding protein gene with multiple splicing; GAPDH represents glyceralde-
hyde-3-phosphate dehydrogenase.
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and maintained by the Developmental Studies Hybridoma
Bank, University of Iowa) directed against annexins I and II
[15]. Antibody binding was visualized using horseradish per-
oxidase based staining as described previously [13]. Negative
controls included sections not exposed to the primary anti-
body.
RESULTS
 Laser capture microdissection (LCM) was used to obtain
material from the ganglion cell layer, referred to herein as
“GCL fraction” (Figure 2). Care was taken to avoid retinal
vessels, although some capillaries could not reliably be iden-
tified and may have been inadvertently collected. In addition,
a similar amount of material was isolated from both the inner
and outer retinal nuclear layers as well as the inner and outer
plexiform layers, referred to as the “outer retina” fraction (OR),
was obtained and pooled from the same donor eyes. Success-
ful microdissection was initially evaluated through examina-
tion of the LCM cap after capture and through examination of
the tissue sections before and after LCM (Figure 2). RNA iso-
lated from the collected fractions was amplified and gene ex-
pression levels were determined by microarray analyses. The
complete data from all six hybridizations are included in Ap-
pendix 1.
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Figure 2. Laser capture microdis-
section of unfixed sections of hu-
man retina.  Despite the reduced
morphological preservation in-
herent in unfixed tissue, the dis-
tinct layers of the retina are
clearly discernible. This series of
images demonstrates that isolates
of ganglion cell layer (GCL) or
OR of high purity can be ob-
tained. A: Tissue prior to capture.
B: Remaining tissue after capture
of the GCL, C: Remaining tissue
after capture of the OR, E: iso-
lated GCL material. F: Isolated
OR material. Vertical bars mark
areas collected for analyses. D:
Histological appearance of adja-
cent portions of the retina from
the same donor stained with he-
matoxylin and eosin. (INL repre-
sents inner nuclear layer, ONL
represents outer nuclear layer).
Figure 3. Expression ratios of previously characterized retinal genes.
Expression ratios of genes known to be exclusively expressed either
in the outer nuclear layer (NRL, SAG, RHO) or the ganglion cell
layer (GCL; NFLH, POU4F1) as determined by gene array analysis
following laser capture microdissection (LCM). Substantial enrich-
ment of these gene products in the respective fractions indicated suc-
cessful LCM purification. Relative expression is defined as the ratio
between the expression levels detected in the GCL and the OR.
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TABLE 2. TRANSCRIPTS DETECTED AT VERY HIGH LEVELS BY GENE
ARRAY ANALYSES OF THE HUMAN GANGLION CELL LAYER
Although the signal intensity of different probe sets is not strictly
correlated, the genes listed here are likely to represent highly abun-
dant transcripts of the ganglion cell layer. Duplicate genes, genes
encoding ribosomal proteins, and uncharacterized transcripts or hy-
pothetical proteins have been removed from this list. Average ex-
pression values (Avg) are given in normalized fluorescence units.
An unabridged table listing all genes expressed in the GCL is in-
cluded in Appendix 1.
Following microarray analyses the purity of each GCL
and OR pair was further evaluated through the comparison of
expression values of additional genes that have been previ-
ously demonstrated to be selectively expressed either by pho-
toreceptor or ganglion cells. The results demonstrate that rela-
tive levels of photoreceptor genes are dramatically reduced in
the RGC preparations, whereas gene products that are ex-
pressed in RGC are highly enriched and served as further con-
firmation of sample purity (Figure 3).
Of the over 54,000 probe sets contained on the Genechips
used approximately 31% were detected as “present” in each
of the GCL samples by the Affymetrix software (GCOS 1.4).
We subsequently identified 9,297 probe sets that were consis-
tently present in all GCL samples and sorted them by the av-
erage expression level. The resulting list represents a catalog
of gene expression in the adult human GCL (Table 2).
Displaced amacrine cells represent a significant portion
of all cells in the GCL, but amacrine cells are also present in
the inner nuclear layer. Amacrine cell-derived mRNA is ex-
pected to be present in both collected fractions, albeit pre-
sumably at higher normalized levels in the GCL due to the
higher proportion of amacrine cells in the total cell population
of the GCL when compared to the inner and outer nuclear cell
layers. In order to remove sequences that are likely to be ex-
pressed by this cell type, we defined the ratio of expression in
the GCL and the OR fraction for the amacrine cell markers
parvalbumin, calretinin, and glutamate decarboxylase 1 [16-
18]. In our data set we found that these transcripts are 2-4
times more abundant in the GCL fraction than in the OR frac-
tion. Based on these findings, only genes with at least a 10
fold difference between the GCL and OR fractions were fur-
ther considered. Using Student’s t-test, we identified 115 probe
sets belonging to 85 different annotated genes that appeared
to be significantly enriched in the GCL. Data were also ana-
lyzed for differential expression using Significance Analysis
of Microarrays (SAM) [12]. Under the condition used, 128
distinct genes were found to be significant which included all
but two genes identified by t-test. These identified transcripts
most likely represent RGC or retinal astrocyte specific genes
(Table 3).
In order to confirm elevated expression in the GCL of a
number of the identified genes, we carried out real time PCR
analyses for five selected gene transcripts. Preference was
given to those genes whose expression pattern in the retina
has not been clearly demonstrated, including STMN2
(stathmin-like 2), SRPX (X-linked sushi-repeat-containing
protein), ELAV2 (embryonic lethal, abnormal vision-like 2),
RBPMS (RNA binding protein with multiple splicing), and
PRPH (peripherin, an intermediate neurofilament distinct from
the retinal degeneration gene RDS). Data obtained demon-
strated that transcripts from these genes are nearly undetect-
able in the OR but can readily be identified in the GCL frac-
tion (Figure 4).
GCL-specific expression and protein localization of
annexin A2 was further evaluated immunohistochemically
(Figure 5). Labeling to discrete focal regions in the GCL was
reproducibly observed in three individual human donors
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whereas only minor reactivity was observed in other portions
of the neural retina. However, large retinal and choroidal ves-
sels also displayed marked immunoreactivity (data not shown).
The observed labeling with the annexin antibody did not co-
localize with antibodies directed against the cell type markers
CD68 (microglia), GFAP (astrocytes), or ThyI (RGC).
DISCUSSION
 LCM has been used extensively for analyses at the DNA and
RNA level, and numerous studies have described the use of
laser-captured material for global analyses of gene expression
using cDNA microarrays [19]. The development of various
protocols for linear amplification of mRNA facilitated the in-
vestigation of small amounts of RNA template and has been
shown to maintain relative mRNA levels both when ampli-
fied samples are compared to one other as well as when com-
pared to unamplified samples [20,21]. Herein we used both
LCM and microarray analyses to determine the expression
profile of the human adult retinal GCL and to identify those
genes whose expression is limited to this retinal layer.
The microarrays used contain over 54,000 probe sets
which likely represent the vast majority of all genes of the
human genome. Of these, we detected over 9,200 genes which
appear to be consistently present in the human GCL, although
it is possible that a small fraction of expressed genes might
remain undetected due to poor probe set design, insufficient
length of the synthesized cRNA probe, or other technical fac-
tors. In addition, while RNA quality from donor eyes preserved
within a short time after death is generally high [22], it is con-
ceivable that the absence or presence of individual gene prod-
ucts is influenced by post-mortem events, such as cessation of
perfusion.
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TABLE 3. GENES EXPRESSED PREDOMINATELY IN THE GANGLION CELL
LAYER
Genes expressed at least at 10 fold higher levels in the GCL than in
other parts of the retina, as identified both by SAM and t-test, and
grouped by putative function. Hypothetical gene products or
uncharacterized sequences were removed from this list. Average ex-
pression values (ganglion cell layer and OR) are given in normalized
fluorescence units.
Figure 4. Real-time PCR confirmation of ganglion cell layer specific
gene expression.  Transcripts for all analyzed genes were either ab-
sent or present at very low levels in the OR fraction whereas they
were readily detected in the ganglion cell layer.
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These genes may be expressed by any of the cell types
residing in the GCL: various subtypes of RGC, amacrine cells,
glia or endothelial cells and pericytes. Comparison of the genes
expressed in the GCL to those expressed in other portions of
the retina allowed the identification of over 80 genes whose
expression appears to be limited to the GCL. Since RGC and
astrocytes are only found in the GCL, it is likely that these
cell types contribute the vast majority of the GCL-specific
transcripts. However, it is conceivable that GCL-specific tran-
scripts exist in cell types present throughout the retina (e.g.
microglia, capillary pericytes or Mueller cell end feet).
Although the functions of many of the identified genes
are incompletely described in the literature, we noted several
distinct functional groups among the GCL-specific genes. The
first group contains genes encoding cytoskeletal components,
such as the well characterized RGC-specific neurofilaments,
and other molecules implicated in cytoskeletal organization,
maintenance of axonal caliber, and axonal transport (e.g.
epiplakin 1 or the kinesin family member 5A).
Another prominent functional group appears to be related
to endo- and exocytosis as well as intracellular vesicular trans-
port. This group includes such genes as CPLX1 (complexin
1), which promotes neurotransmitter release through interac-
tion with the SNARE complex, and RAB13 which specifi-
cally mediates endocytic recycling [23,24]. Collectively these
molecules may facilitate neurotransmitter release, reuptake and
turnover by RGC and their associated glia.
A third prominent group of GCL-specific molecules con-
tains genes involved in gene transcription and RNA process-
ing, including well known RGC-specific transcription factors
such as Brn3a [25], but also genes previously undescribed in
the human retina such as the ELAVL2 and ELAVL4 transcripts.
These genes encode vertebrate homologues of the drosophila
ELAV (Embryonic Lethal, Abnormal Vision) gene family,
which has been implicated in functions related to mRNA sta-
bility and translatability [26].
Finally, we identified a number of GCL transcripts in-
volved in ion and amino acid transport. This group contains
several K+ and Ca+ channels, e.g. Kv 1.2 (KCNA2) or volt-
age gated sodium channels (SCN1A and B), as well as the
Na+/K+ transporting beta-1 ATPase (ATP1B1). Voltage-de-
pendent sodium and potassium channels are crucial for the
generation and propagation of action potentials and thus to
the function of RGC.
Many of the genes identified in our study have previously
been reported to be either RGC- or glial cell-specific in a num-
ber of studies focused on individual molecules. For example,
Fyk-Kolodziej et al. reported that the distribution of the ve-
sicular glutamate transporter SLC17A6 (VGLUT2) is re-
stricted to ganglion cells [27]. In addition, several of the genes
identified as GCL-specific in this study, such as stathmin-like2,
have also been reported by other investigators employing high-
throughput gene expression profiling approaches [7,8]. Oth-
ers in contrast, have been previously less well characterized.
Examples for such genes include SRPX (sushi-repeat-contain-
ing protein), which has previously been suspected to be in-
volved in x-linked retinitis pigmentosa, but does not appear to
be expressed in the inner or outer nuclear layer [28], or RBPMS
(RNA binding protein with multiple splicing) which has not
been previously described in the retina [29].
Two previously published studies examined gene expres-
sion in purified rat RGCs [7,8]. Farkas and colleagues used a
2-step panning procedure to isolate RGCs from dissociated
retinas of Sprague-Dawley rats, followed by RNA extraction,
preparation of a cDNA library, and extensive sequencing of
this library [8]. Ivanov and colleagues used a similar 2-step
panning procedure to purify RGCs from adult Brown-Nor-
way rats, but profiled gene expression using gene chips [7].
When comparing the results of these two studies with our data,
it is important to recognize the advantages and limitations of
the techniques used. As discussed previously, the retinal GCL
contains other cell types in addition to RGCs, and LCM did
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Figure 5. Immunohistochemical detection of annexin II in the normal human retina.  In accordance with the observed gene expression profile,
annexin immunoreactivity is primarily observed in distinct areas of the GCL (arrows) and, to a lesser degree, diffusely in the nerve fiber layer
(A). No labeling was observed in the absence of the primary antibody (B).
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not differentiate between these cell types. In contract, the iso-
lated rat RGC preparations contained >95% RGCs. However,
LCM captures the ganglion layer cells in a more natural, na-
tive environment. The isolated purified RGCs are axotomized,
dissociated from connecting retinal cells, and partially cul-
tured prior to gene expression profiling, which undoubtedly
alters the expression of some genes. Despite these important
methodological differences between the studies, many of the
genes identified in isolated rat RGC could also be detected in
this study in the human GCL, including: CHRNB3, PRPH,
STMN2, NRN1, NEF3, NEFL, and various members of the
RGS family of genes.
The retinal samples evaluated in this study were obtained
from near- to mid peripheral portions of the eye. Clearly cer-
tain anatomical differences between the ganglion cells of the
macula and peripheral retina exist [30]. Accordingly it is likely
that the gene expression profile of the macular GCL is in some
aspects distinct from the one reported herein. However, the
retinal regions evaluated are particularly vulnerable to glau-
comatous damage. Despite the wide spread occurrence of glau-
coma, relatively little is known about the cellular mechanisms
involved in the etiology of the disease or about the genetic
risk factors that confer heightened susceptibility to glauco-
matous vision loss. The characterization of genes expressed
in adult human ganglion or glial cells may be useful in the
identification of risk factors or candidate genes for hereditary
forms of glaucoma. Furthermore, while apoptosis appears to
be the final mechanism of RGC death, other degenerative
mechanisms appear to be involved and may be mediated by
GCL glial cells [31-34]. Current glaucoma therapy relies upon
the reduction of intraocular pressure. Unfortunately, in some
patients IOP reduction alone does not completely halt RGC
demise and reduction of vision, indicating the need to devise
additional treatment regimens aimed specifically at ganglion
cell survival. Such approaches might involve the generation
of RGC-specific gene therapy vectors or the development of
drugs designed to interact specifically with these cells. It is
our hope that the data presented will aid in this process.
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